"> Bravado Health’s EPCS Certification Success with Drummond – Drummond Group

CASE STUDY

Bravado Health’s EPCS Certification Success with Drummond

Bravado Health Gives Customers Confidence with EPCS Certification

Challenge

In 2012, the year after the Drug Enforcement Administration (DEA) approved electronic prescribing of controlled substances (EPCS), EPCS adoption was very low. In fact, only several states allowed EPCS. Nevertheless, Bravado Health, recognized the importance of EPCS and looked for an auditor that was approved by the DEA. Drummond was one of the first to have their EPCS certification process approved by the DEA. To meet the new EPCS 21 CFR 1311 requirements, Bravado Health turned to Drummond as a trusted partner. Bravado Health had previously engaged Drummond for ONC EHR certification and was impressed by Drummond’s attention to their customers. As Drummond’s first EPCS client over eight years ago, Bravado Health has maintained certification with Drummond for EPCS compliance to mitigate risks for their customers.

Approach

Drummond’s EPCS certification process, with a strong emphasis on requirements review, was essential in guiding Bravado Health through the complicated detail in 21 CFR 1311 Final Rule for EPCS. With this clear understanding of the DEA’s requirements, Bravado Health in turn had confidence to start development of the application requirements in their product. This guidance allowed Bravado Health to save many hours of research and to begin development sooner.

During the development process Drummond scheduled regular meetings to address ongoing questions, as well as provided technical expertise on two-factor authentication, identify proofing, biometrics, and security and digital certificates.

“As a longtime client of Drummond, we have found a proven partner for compliance around the DEA EPCS regulatory requirements. Drummond has shared their expertise and proven methodologies to ensure we maintain compliance as required.“

Gary Barton, Chief Software Officer, Bravado Health

Results

Drummond’s EPCS certification process, with a strong emphasis on requirements review, was essential in guiding Bravado Health through the complicated detail in 21 CFR 1311 Final Rule for EPCS. With this clear understanding of the DEA’s requirements, Bravado Health in turn had confidence to start development of the application requirements in their product. This guidance allowed Bravado Health to save many hours of research and to begin development sooner.

During the development process Drummond scheduled regular meetings to address ongoing questions, as well as provided technical expertise on two-factor authentication, identify proofing, biometrics, and security and digital certificates.

About Bravado Health

Bravado Health was founded by physicians and engineers in 1998 to streamline the discharge process. From its origin in discharge technology, Bravado Health expanded its portfolio to patient engagement and web-based applications. Today, Bravado Health provides solutions for some of the nation’s most recognizable and innovative healthcare organizations. Bravado Health’s newest platform, Ayva, extends beyond the point of care by offering web-based health experiences.

Your Trusted Compliance Partner

Drummond is ready to help you incorporate continuous security and compliance practices into your organization and culture. Experience our team of highly skilled experts ready to collaborate with you and your team. Increase trust, gain expertise and experience our unique approach and attention to detail as we partner with you to achieve compliance, application conformance and protect your business with advanced cyber-security practices.

EPCS Background

Electronic Prescriptions for Controlled Substances (EPCS) is a Federal Rule which allows for the electronic transmission of prescriptions of Controlled Substances. In response to the rising prescription drug abuse problem, the US Drug Enforcement Administration (DEA) and states worked together to create programs and legislation to deter abuse and misuse. EPCS has mandates at the national and local levels governed by the DEA to reduce the potential for diversion, and subsequent abuse of controlled substances.

The DEA Title 21 CFR provides guidance for EPCS. EPCS technology is addressing the problem of forged or stolen prescriptions by requiring authentication of prescribers, improving security standards, and auditing activity on EPCS platforms. States that mandate this today include New York, Maine, Connecticut and Pennsylvania. By 2022 half the states in the US will mandate EPCS certification.

Ready to learn how Drummond can help you
become EPCS certified?

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

Click to enable/disable Google Analytics tracking code.
Click to enable/disable Google Fonts.
Click to enable/disable Google Maps.
Click to enable/disable video embeds.
Our website uses cookies, some from third-party services. Define your Privacy Preferences and/or agree to our use of cookies.